4//SEC Filing
Prokupets Elena 4
Accession 0001209191-21-057118
CIK 0001662579other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 7:26 PM ET
Size
11.1 KB
Accession
0001209191-21-057118
Insider Transaction Report
Form 4
Prokupets Elena
Director
Transactions
- Sale
Common Stock
2021-09-21$50.14/sh−5,333$267,410→ 526,364 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-17$50.05/sh−5,688$284,687→ 531,697 total(indirect: By ERP Business Holdings, LP) - Sale
Common Stock
2021-09-21$50.13/sh−4,988$250,051→ 43,036 total(indirect: By Spouse) - Sale
Common Stock
2021-09-17$50.04/sh−5,152$257,808→ 48,024 total(indirect: By Spouse)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
- [F4]Shares held by ERP Business Holdings, L.P. The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001824823
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 7:26 PM ET
- Size
- 11.1 KB